Furthermore, AUY922 in combination with the PI3K/mTOR dual inhibitor GSK458 induced apoptosis and reduced compensatory pathway activation in KRAS-mutant NSCLC [187]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.